A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19
Volume: 42, Pages: 102182 - 102182
Published: Jul 1, 2020
Abstract
BackgroundTreatment decisions in patients with multiple sclerosis (MS) during the coronavirus disease 2019 (COVID-19) pandemic are challenging. It is not known whether and how various disease modifying therapies, especially immunosuppressive drugs, affect COVID-19 risk and disease course.MethodsCase reportResultsWe report a fingolimod-treated MS patient who developed severe COVID-19 but recovered after treatment with tocilizumab.ConclusionThis...
Paper Details
Title
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19
Published Date
Jul 1, 2020
Volume
42
Pages
102182 - 102182
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History